Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
04/2003
04/23/2003EP1303521A1 Tetrahydro-heterocycloazepinyl pyrimidine derivatives
04/23/2003EP1303520A1 Therapeutic compounds and methods
04/23/2003EP1303517A1 Indoloquinazolinones
04/23/2003EP1303512A1 Process for preparing arylacetylaminothiazoles
04/23/2003EP1303507A1 Pyrimidine derivatives
04/23/2003EP1303506A1 6-heteroarylphenanthridines
04/23/2003EP1303503A2 Aniline derivatives
04/23/2003EP1303501A1 Cyanomethyl substituted thiazoliums and imidazoliums and treatments of disorders associated with protein aging
04/23/2003EP1303497A1 Substituted amidoalkyl-uracils as parp inhibitors
04/23/2003EP1303496A1 Pyrimidine derivatives
04/23/2003EP1303494A2 Potassium channel inhibitors
04/23/2003EP1303492A2 Aza-bridged-bicyclic amino acid derivatives as alpha 4 integrin antagonists
04/23/2003EP1303490A1 N-oxides as nk1 receptor antagonist prodrugs of 4-phenyl-pyridine derivatives
04/23/2003EP1303486A1 Pyrrolidine derivatives as metalloprotease inhibitors
04/23/2003EP1303485A1 Pyrrolidine derivatives as inhibitors of endothelin-converting enzyme
04/23/2003EP1303482A2 N-substituted-1-amino-1,1-dialkylcarboxylic acid derivatives
04/23/2003EP1303478A1 Process for the preparation of substituted octanoyl amides
04/23/2003EP1303310A1 USE OF THE INTERFERON RECEPTOR 2c POLYPEPTIDE CHAIN TO ENHANCE THE ANTI-GROWTH EFFECTS OF TYPE I INTERFERONS
04/23/2003EP1303308A2 Aldosterone antagonist and cyclooxygenase-2 inhibitor combination therapy to prevent or treat inflammation-related cardiovascular disorders
04/23/2003EP1303306A2 Epoxy-steroidal aldosterone antagonist and beta-adrenergic antagonist combination therapy for treatment of congestive heart failure
04/23/2003EP1303305A2 Epoxy-steroidal aldosterone antagonist and calcium channel blocker combination therapy for treatment of congestive heart failure
04/23/2003EP1303304A2 Pharmaceutical combinations for treatment and prevention of diabetes mellitus
04/23/2003EP1303294A2 Method for treating unstable angina pectoris
04/23/2003EP1303279A1 Method of treating peripheral vascular diseases, peripheral neuropathies, and autonomic neuropathies
04/23/2003EP1303264A1 Compositions and methods for treating cardiovascular disorders
04/23/2003EP1257537A4 Therapeutic morpholino-substituted compounds
04/23/2003EP1254131A4 Extraction of flavonoids
04/23/2003EP1222183B1 Benzopyran derivatives
04/23/2003EP1220863B1 Purine derivatives
04/23/2003EP1218378B1 Tert.-butyl-(7-methyl-imidazo[1,2-a]pyridine-3-yl)-amine derivatives
04/23/2003EP1185175B1 Method of increasing the content of flavonoids and phenolic substances in plants
04/23/2003EP1131072B1 Pharmaceutical combination preparations in solid dosage form of carvedilol and hydrochlorothiazide
04/23/2003EP1117681B1 Rho-cocotoxin peptides having selective alpha-1 adrenoceptor activity
04/23/2003EP1045690B1 Benzenesulfonamide inhibitors of pde-iv and their therapeutic use
04/23/2003EP0699072B1 Use of iron-binding polymers for the manufacture of a medicament for oral administration
04/23/2003CN1413250A Method of producing differentiated progenitor cells and lineage-defective embryonic stem cells
04/23/2003CN1413230A Highly-neutralized ethylene copolymers and their use in golf balls
04/23/2003CN1413213A Azaindoles
04/23/2003CN1413210A Non-peptidyl inhibitors of VLA-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases
04/23/2003CN1413207A 5-membered ring heterocyclic compounds with nitrogen
04/23/2003CN1413206A Non peptide tachykinin receptor antagonists
04/23/2003CN1413198A Methods and compositions utilizing quianzolinones
04/23/2003CN1413196A 2-Arylquinoline derivatives, preparation and therapeutic use thereof
04/23/2003CN1413193A Nitrile derivatives as cathepsin K inhibitors
04/23/2003CN1413192A Substituted indole mannich bases
04/23/2003CN1413189A Benzamidine derivatives
04/23/2003CN1413186A Aminobenzophenones as inhibitors of IL-1 beta and TNF-alpha
04/23/2003CN1413185A Substitued 1 and 2 naphthol mannich bases
04/23/2003CN1413107A Use of hypoglycemic agent for treating impaired clucose metabolism
04/23/2003CN1413105A Novel method of treatment
04/23/2003CN1413104A New (aminopropyl) methylphosphinic acids
04/23/2003CN1412303A Recombinant gland related virus expressing human kallikrein, its preparation method and application
04/23/2003CN1412181A Carboxylic acid derivative capable of inhibiting combination of integrin and its receptor
04/23/2003CN1411848A Chinese medicine liquor for clearing and activating channels and collaterals
04/23/2003CN1411846A Chinese medicine pressure-raising oral liquor
04/23/2003CN1411845A Oral Chinese medicine for curing cerebrovascular disease
04/23/2003CN1411839A Medicine for curing encephalasthenia syndrome and its preparation method
04/23/2003CN1411832A Taxus chinensis health-care composition for reducing blood pressure
04/23/2003CN1411830A Medicine for curing hypertension and its preparation method
04/23/2003CN1411821A Medicine for curing angiocardiopathy and its preparation method
04/23/2003CN1411816A New anticoagulant medicine
04/23/2003CN1411811A 血液循环改善剂 Blood circulation improving agent
04/23/2003CN1411809A Usage and composition of pyridine onium derivative for curing application
04/23/2003CN1411800A Cosmetic composition and method
04/23/2003CN1106384C Indoline-2-one derivatives, its preparing method and its medicinal compositions
04/23/2003CN1106379C 2-propyl valeramide and 2-propyl valeramide derivative and medical use as anticonvulsants
04/23/2003CN1106270C Multi-action particle for structuring biological media
04/23/2003CN1106195C Use of thazolinedione derivatives and related antihyperglycemic agents in treatment of disease states at risk for progressing to non-insulin-dependent diabetes mellitus
04/23/2003CA2403307A1 Substituted 2-cyclohexyl-4-phenyl-1h-imidazole derivatives
04/22/2003US6552225 Such as n-(2,3-dichloro-4-(methylaminosulphonyl)phenyl)-3,3,3-trifluoro-2-hydroxy-2 -methylpropanamide; diabetes, obesity, lactic acidaemia
04/22/2003US6552223 N-hydroxacylamino compounds, process for their preparation and pharmaceutical compositions containing them
04/22/2003US6552188 Unsymmetrical cyclic diamine compound
04/22/2003US6552168 Inhibition of apoptosis via attenuation of caspase activity should therefore be useful in the treatment of human diseases where inappropriate apoptosis is prominent or contributes to disease pathogenesis
04/22/2003US6552083 Administering therapeutically effective amount of N-(3,4-dimethoxycinnamoyl)anthranilic acid or its salt
04/22/2003US6552077 Kidney disorders
04/22/2003US6552073 Compounds and methods of treating cell proliferative diseases
04/22/2003US6552071 Methods for treating cell death diseases and inflammation
04/22/2003US6552062 For therapy of central nervous system disorders; damage to the central nervous system; cardiovascular disorders; gastrointestinal disorders; diabetes insipidus, and sleep apnea, and obesity
04/22/2003US6552058 Oxazolidinedione derivatives and their use
04/22/2003US6552051 Useful as high energy oxidizing agents in explosive and propellant formulations, and drugs for vasodilation
04/22/2003US6552048 Sulfonylcarboxamide derivatives, process for their preparation and their use as pharmaceuticals
04/22/2003US6552046 Cisapride
04/22/2003US6552044 Indane or dihydroindole derivatives
04/22/2003US6552043 Benzimidazolinyl piperidines as CGRP ligands
04/22/2003US6552036 3-(Diarylmethylene)-8-azabicyclo[3.2.1]octane derivatives
04/22/2003US6552033 Imidazo-containing heterocyclic compounds, their compositions and uses
04/22/2003US6552030 Inhibit human factor Xa; treating thrombotic activity; 3-((3,5-difluoro-6-(3-(1-methylimidazolin-2-yl)phenoxy)-4-((2-(1,2 -dihydoxyethyl)-4-hydroxy-5-ethoxytetrahydrofuran-3-yl)oxy)-pyridin-2 -yl)oxy)4-hydroxybenzamidine
04/22/2003US6552022 Atherosclerosis in a mammal, pancreatitis, non-insulin dependent diabetes mellitus, coronary heart disease in a lowering serum lipid levels
04/22/2003US6552019 Inhibitors of p38
04/22/2003US6551990 Methods of inhibiting ectopic calcification
04/22/2003US6551792 Nucleotide sequence which encodes a flavin monooxygenase, the corresponding protein and their uses in the spheres of diagnosis and therapy
04/22/2003US6551626 Composition containing pyrrolizidine-alkaloid-free petasites
04/22/2003CA2308780C Novel derivatives of 2,3-methanoamino acids, process for their preparation and pharmaceutical compositions containing them
04/22/2003CA2292673C Pharmaceutical compositions containing eletriptan hemisulphate
04/22/2003CA2287054C 1,3,8-triazaspiro¬4,5|decanone compounds as orl1-receptor agonists
04/22/2003CA2281580C Quinoxalinediones
04/22/2003CA2068630C Use of protein c or activated protein c
04/19/2003CA2361863A1 Composition and method for use of pyridinium derivatives in cosmetic and therapeutic applications
04/17/2003WO2003031940A2 Structural and cytoskeleton-associated proteins
04/17/2003WO2003031939A2 Protein modification and maintenance molecules
1 ... 1020 1021 1022 1023 1024 1025 1026 1027 1028 1029 1030 1031 1032 1033 1034 1035 1036 1037 1038 1039 1040 ... 1595